Biomarkers are used to improve diagnosis and monitor a therapeutic response. During biomarker discovery ideal candidates are identified.
Browsing: biomarker assay validation
In this interview Robert Nelson, Associate Director of Science and Innovation at Covance (Geneva, Switzerland) discusses the importance of biomarkers in drug development, describing key aspects in the current guidance and key considerations to make in the development and validation process.
Find out more about the current situation for biomarker research in Japan in this Editorial from Bioanalysis.
In this interview we talk to Timothy Olah (Bristol-Myers Squibb) about his research and role as Group Director. He discusses his group’s responsibility for developing quantitative methods to measure novel therapeutics and biomarkers in discovery.